Plain-English translation of NCT06530251 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new immunotherapy drug called to treat advanced liver cancer. The study has two parts: first, researchers will figure out the right dose and watch for side effects; second, they will test whether works better alone or when combined with other medications, compared to current standard treatments.
Advanced liver cancer is difficult to treat, and many patients don't respond well to existing therapies or cannot receive them. This trial is exploring whether this medication, alone or combined with others, can help patients whose cancer has progressed despite other treatments.
You likely qualify if…
You likely don't qualify if…
You will receive the study medication either alone or combined with other drugs through regular clinic visits. The study has two phases: in Phase 1b, researchers are determining the safest dose and monitoring side effects closely; in Phase 2, they will compare how well the medication works compared to standard treatments. You will have blood tests, imaging scans, and regular check-ins with your care team to monitor your response and any side effects.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China